共 240 条
[21]
Theirs V(2012)Long-term impact of prophylactic antiviral treatment in Hepatitis B surface antigen positive renal allograft recipients Clin Nephrol 78 303-95
[22]
Harnett JD(2009)Efficacy and tolerability of lamivudine in hepatitis B infected renal transplant recipients: a single center study Indian J Nephrol 19 91-1627
[23]
Zeldis JB(1997)Efficacy and safety of lamivudine on replication of recurrent hepatitis B after cadaveric renal transplantation Transplantation 64 1624-737
[24]
Parfrey PS(1998)Treatment of chronic hepatitis B with lamivudine in renal transplant recipients Transplantation 66 733-1407
[25]
Kennedy M(2000)Twelve months of lamivudine treatment for chronic hepatitis B virus infection in renal transplant recipients Transplantation 70 1404-957
[26]
Sircar R(2001)Surface antigen-positive organ transplantation recipients: can lamivudine alter their fate? J Gastroenterol Hepatol 16 955-1531
[27]
Steinmann TI(2004)Lamivudine for patients with chronic hepatitis B and advanced liver disease N Engl J Med 351 1521-795
[28]
Rao KV(2011)Does antiviral therapy prevent hepatocellular carcinoma? Antivir Ther 16 787-1936
[29]
Kasiske BL(2000)Managing hepatitis B reactivation in renal transplant recipients: a 12-year review with emphasis on early detection and early use of lamivudine Transpl Proc 32 1935-181
[30]
Anderson WR(1998)Treatment of fibrosing cholestatic hepatitis with lamivudine Gastroenterology 115 177-1944